Stock Events

Stock Events

Premier Biomedical 

$0.000600
1
+$0.00+0% Thursday 18:30

Statistics

Day High
0.0006
Day Low
0.0005
52W High
0.002
52W Low
0.0003
Volume
1,634,662
Avg. Volume
18,517,425
Mkt Cap
779,988.6
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

15MayExpected
Q2 2018
Q3 2018
Q1 2019
Q2 2019
Q3 2019
Q3 2019
Q1 2020
-0.14
-0.09
-0.05
-0
Expected EPS
N/A
Actual EPS
-0.0004

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-87,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap366B
Merck & Co., Inc. is a global healthcare company that develops medications and vaccines for many of the same diseases that Premier Biomedical targets, making them direct competitors in the pharmaceutical and biotech industry.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. operates in the pharmaceutical and biotechnology industry, developing and marketing drugs and vaccines for diseases that overlap with Premier Biomedical's research areas, positioning them as competitors.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson is a comprehensive healthcare company that engages in the research and development of pharmaceuticals and biotechnological treatments, competing in similar therapeutic areas as Premier Biomedical.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc. focuses on pharmaceuticals, including therapies for conditions that Premier Biomedical is also targeting, making them competitors in the biopharmaceutical sector.
AMGEN
AMGN
Mkt Cap233.78B
Amgen Inc. is a biopharmaceutical company that develops innovative therapies, including for diseases that Premier Biomedical is also interested in, making them direct competitors in the biotech industry.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol-Myers Squibb Company is involved in the discovery, development, and marketing of drugs in areas that overlap with Premier Biomedical's interests, making them competitors in the pharmaceutical industry.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences, Inc. focuses on the development and marketing of drugs in areas such as infectious diseases, a field that Premier Biomedical may also be involved in, positioning them as competitors.
Novartis
NVS
Mkt Cap292.35B
Novartis AG is a global healthcare company that researches and develops drugs in many of the same therapeutic areas as Premier Biomedical, making them direct competitors in the pharmaceutical industry.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG engages in the research and development of pharmaceuticals and diagnostics, competing in similar fields as Premier Biomedical, especially in oncology and immunology.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is a global life sciences company that focuses on healthcare solutions, including pharmaceuticals and vaccines, in areas that overlap with Premier Biomedical's research, making them competitors.

About

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer’s disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.
Show more...
CEO
Ivan Mendez
Employees
4
Country
United States
ISIN
US74048K2033

Listings

OTC Link
US
BIEI

0 Comments

Share your thoughts

FAQ

What is Premier Biomedical stock price today?▼
The current price of BIEI is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Premier Biomedical stock price performance more closely on the chart.
What is Premier Biomedical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Premier Biomedical stocks are traded under the ticker BIEI.
Is Premier Biomedical stock price growing?▼
BIEI stock has fallen by -0% compared to the previous week, the month change is a -25% fall, over the last year Premier Biomedical has showed a -50% decrease.
What is Premier Biomedical market cap?▼
Today Premier Biomedical has the market capitalization of 779,988.6
What were Premier Biomedical earnings last quarter?▼
BIEI earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Premier Biomedical revenue for the last year?▼
Premier Biomedical revenue for the last year amounts to 0 USD.
What is Premier Biomedical net income for the last year?▼
BIEI net income for the last year is -87,000 USD.
How many employees does Premier Biomedical have?▼
As of September 04, 2026, the company has 4 employees.
In which sector is Premier Biomedical located?▼
Premier Biomedical operates in the Health & Wellness sector.
When did Premier Biomedical complete a stock split?▼
The last stock split for Premier Biomedical was on June 27, 2018 with a ratio of 1:250.
Where is Premier Biomedical headquartered?▼
Premier Biomedical is headquartered in Knoxville, United States.